We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Matador Resources
MTDR
$7.02B
| $12.2M | 0.02% |
255,870
-118
| -0% | -$5.21K |
|
527
Novartis
NVS
$294B
| $12.1M | 0.02% |
99,603
-1,473
| -1% | -$166K |
|
528
BridgeBio Pharma
BBIO
$15.4B
| $12M | 0.02% |
+277,587
| New | +$10.1M |
|
529
Resideo Technologies
REZI
$3.03B
| $11.9M | 0.02% |
541,332
-809,221
| -60% | -$15.4M |
|
530
The Mosaic Company
MOS
$7.55B
| $11.9M | 0.02% |
325,733
-6,475
| -2% | -$207K |
|
531
Credo Technology Group
CRDO
$45.1B
| $11.9M | 0.02% |
128,169
-57,431
| -31% | -$3.35M |
|
532
Allegiant Air
ALGT
$2.2B
| $11.8M | 0.02% |
215,531
+24,557
| +13% | +$1.27M |
|
533
Builders FirstSource
BLDR
$7.23B
| $11.8M | 0.02% |
101,081
+31,846
| +46% | +$3.67M |
|
534
Brinker International
EAT
$10B
| $11.8M | 0.02% |
65,239
-7,558
| -10% | -$1.19M |
|
535
H&R Block
HRB
$6.47B
| $11.7M | 0.02% |
213,993
+121,131
| +130% | +$6.99M |
|
536
Devon Energy
DVN
$51.8B
| $11.7M | 0.02% |
366,255
-117,554
| -24% | -$3.74M |
|
537
Essential Properties Realty Trust
EPRT
$6.57B
| $11.5M | 0.02% |
359,948
+131,039
| +57% | +$4.19M |
|
538
MKS Inc
MKSI
$18.3B
| $11.5M | 0.02% |
115,590
+31,815
| +38% | +$2.59M |
|
|
MNTN
539
MNTN Inc
MNTN
$943M
| $11.5M | 0.02% |
+525,000
| New | +$12.1M |
|
540
Doximity
DOCS
$4.56B
| $11.5M | 0.02% |
186,986
-89,985
| -32% | -$5.02M |
|
541
Snap-on
SNA
$20.5B
| $11.4M | 0.02% |
36,734
+8,106
| +28% | +$2.58M |
|
542
Rockwell Automation
ROK
$48.1B
| $11.3M | 0.02% |
34,088
+10,090
| +42% | +$2.87M |
|
|
ETOR
543
eToro Group
ETOR
$2.56B
| $11.3M | 0.02% |
+170,000
| New | +$11M |
|
544
RLI Corp
RLI
$5.89B
| $11.2M | 0.02% |
155,584
-2,850
| -2% | -$214K |
|
545
Booking.com
BKNG
$152B
| $11.2M | 0.02% |
48,450
+2,175
| +5% | +$445K |
|
546
American International
AIG
$40.1B
| $11.2M | 0.02% |
130,909
-7,827
| -6% | -$652K |
|
|
BDN
547
Brandywine Realty Trust
BDN
$534M
| $11.2M | 0.02% |
2,603,041
+14,694
| +0.6% | +$61K |
|
548
Huron Consulting
HURN
$2.54B
| $11.1M | 0.02% |
80,931
-617
| -0.8% | -$87.7K |
|
549
Qorvo
QRVO
$8.49B
| $11.1M | 0.02% |
130,720
+128,611
| +6,098% | +$9.29M |
|
550
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.7B
| $11M | 0.02% |
237,120
+100,600
| +74% | +$4.6M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.